Envelope surface glycoprotein gp120
|
env
|
Tandem affinity purification and mass spectrometry analysis identify DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17), HIV-1 Gag, Gag/Pol, gp120, and Nef incorporated into staufen1 RNP complexes isolated from HIV-1-expressing cells |
PubMed
|
Gag-Pol
|
gag-pol
|
Overexpression of DDX17 DQAD leads to a decrease in frameshift efficiency, suggesting that the helicase activity of DDX17 is involved in maintaining the proper ratio of Gag-Pol expression required for optimal infectivity |
PubMed
|
|
gag-pol
|
Tandem affinity purification and mass spectrometry analysis identify DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17), HIV-1 Gag, Gag/Pol, gp120, and Nef incorporated into staufen1 RNP complexes isolated from HIV-1-expressing cells |
PubMed
|
Nef
|
nef
|
Tandem affinity purification and mass spectrometry analysis identify DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17), HIV-1 Gag, Gag/Pol, gp120, and Nef incorporated into staufen1 RNP complexes isolated from HIV-1-expressing cells |
PubMed
|
Pr55(Gag)
|
gag
|
HIV-1 Gag interacts with DDX17 as demonstrated by proximity dependent biotinylation proteomics and validated via immunoprecipitation and western blot analysis |
PubMed
|
|
gag
|
siRNA knockdown of DDX17 DOES NOT affect intracellular Gag levels but does decrease extracellular (supernatant) CA (p24) levels upon HIV-1 infection |
PubMed
|
|
gag
|
Expression of DDX17 DQAD mutant decreases the amount of HIV-1 CA but not Gag, suggesting that the mutant inhibits Gag processing |
PubMed
|
|
gag
|
Tandem affinity purification and mass spectrometry analysis identify DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17), HIV-1 Gag, Gag/Pol, gp120, and Nef incorporated into staufen1 RNP complexes isolated from HIV-1-expressing cells |
PubMed
|
Rev
|
rev
|
Coexpression of HIV-1 Rev with DDX17 greatly upregulate the expression of HIV-1 CA in HeLa cells |
PubMed
|
|
rev
|
DDX17 interacts with HIV-1 Rev and enhances the Rev function. DDX17 partially co-localizes with Rev in the nucleolus |
PubMed
|
|
rev
|
HIV-1 Rev interacting protein, DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 (DDX17), is identified by the in-vitro binding experiments involving cytosolic or nuclear extracts from HeLa cells. The interaction of Rev with DDX17 is increased by RRE |
PubMed
|
Tat
|
tat
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17) is identified to interact with HIV-1 Tat mutant Nullbasic in HeLa cells by LC MS/MS |
PubMed
|
capsid
|
gag
|
siRNA knockdown of DDX17 decreases intra- and extra-cellular HIV CA(p24) from HeLa cells transfected with env-deleted HIV-1 plasmid, a vesicular stomatitis virus glycoprotein plasmid and specific siRNA. Resulting HIV demonstrates decreased infectivity. |
PubMed
|
|
gag
|
siRNA knockdown of DDX17 decreases extracellular (supernatant) CA (p24) levels upon HIV-1 infection BUT DOES NOT affect intracellular Gag levels |
PubMed
|
|
gag
|
Coexpression of HIV-1 Rev with DDX17 greatly upregulate the expression of HIV-1 CA in HeLa cells |
PubMed
|
|
gag
|
Expression of DDX17 DQAD mutant decreases the amount of HIV-1 CA but not Gag, suggesting that the mutant inhibits Gag processing |
PubMed
|
retropepsin
|
gag-pol
|
Positional proteomics analysis identifies the cleavage of human DEAD (Asp-Glu-Ala-Asp) box helicase 17 (DDX17) at amino acid residues 573-574 by the HIV-1 protease |
PubMed
|